Luisa Cornegliani

Dr. Luisa Cornegliani

Clinica Veterinaria Città di Torino, 10135 Turin, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2021 in Animals
Verified
Journal Article
Open access
PDF file
Eleonora Elisa Alice GuidiEleonora Elisa Alice Guidi
Eleonora Elisa Alice Guidi
AGALESSANDRO GRAMENZI
ALESSANDRO GRAMENZI
PPPaola Persico
Paola Persico
RPRoberta Di Prinzio
Roberta Di Prinzio
DSDaniele Di Simone
Daniele Di Simone
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
Background: an imbalance of the intestinal microbiota can cause health problems in the gastrointestinal tract and in other organs. Canine Atopic Dermatitis (CAD) is a genetically predisposed, inflammatory and pruritic allergic skin disease with multifactorial etiology and multimodal treatment. The aim of this study was to assess the effect of a nutraceutical product on Dysbiotic Index (DI) and the skin lesions of atopic dogs. Methods: a nutraceutical product was administered to 32 dogs with CAD. The product was associated with a standardized hypoallergenic diet for 60 days; the dietary regimen continued for 120 days, while ongoing therapies remained unchanged. Values of Visual Analogic Scale (VAS), Canine Atopic Dermatitis Lesional Index (CADLI) and DI were evaluated on day 0, 60, 120. Results: all the 32 dogs showed a statistically significant decrease (p < 0.001) to V60 of VAS and CADLI, which persisted and increased to V120 when diet alone was continued. The decrease in the DI value was also statistically significant (p < 0.001). Conclusion: the intake of nutraceutical associated with diet resulted in a decrease in the index of intestinal dysbiosis, with an improvement in the subjective severity of cutaneous lesions.

8 May 2018 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
LGLisa Graziano
Lisa Graziano
MVMauro Vasconi
Mauro Vasconi
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
A non-epidermolytic ichthyosis has been identified in Golden Retrievers due to a variant in the PNPLA1 gene, and a genetic test is available to detect wild-type, heterozygous and homozygous dogs. The aims of this study were to investigate the prevalence of the PNPLA1 gene variant in Golden Retrievers used for breeding and to provide more information to breeders in order to restrict the spread of this disease. Clinical examination and assessment of the PNPLA1 genotype using PCR testing of oral swabs were performed in 48 breeding Golden Retrievers. Wild-type, heterozygous or homozygous variants of the PNPLA1 gene were demonstrated in 10 (21%), 23 (48%), and 15 (31%) of the 48 dogs, respectively. In only 3 of the 48 dogs were clinical signs suggestive of ichthyosis identified. Data collected agreed with data reported in the literature. The high prevalence of homozygous and heterozygous variants makes the exclusion of mutated dogs from breeding impractical. Furthermore, the reliability of the PNPLA1 mutation in prediction of clinical signs of ichthyosis is unclear. Additional studies are needed to investigate if PNPLA1 is the only gene involved or if other genes and environmental factors have a role in the development of ichthyosis in Golden Retrievers.

1 September 2011 in Journal of Veterinary Dentistry
Verified
Journal Article
Closed access
PDF file
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
MGMargherita Gracis
Margherita Gracis
SFSilvia Ferro
Silvia Ferro
AVAntonella Vercelli
Antonella Vercelli
Paola RoccabiancaPaola Roccabianca
Paola Roccabianca
Lingual lesions are relatively uncommon in dogs and are mostly represented by neoplasms and glossitis secondary to trauma or infections. Reactive histiocytosis is an uncommon, poorly understood, reactive disorder characterized by proliferation of activated, interstitial, dendritic, antigen-presenting cells associated with lymphocytes and neutrophils with a specific angiocentric orientation and occasional angioinvasion and angiodestruction. Clinically, the disease has a waxing and waning behavior with possible response to treatment and regression, or progression to multiple lesions and internal organ involvement. This case report describes an unusual sublingual presentation of reactive histiocytosis in a Miniature Pinscher dog. The diagnosis was obtained by clinical and histopathological exclusion of other causes, detection of the characteristic microscopic growth pattern, and by immunocytochemistry. Histiocytic cells were vimentin, CD18, CD11c, and CD1c positive consistent with a dendritic cell origin. Anti-BCG stain (Bacillus Calmette and Guerin) was negative for etiological agents. The dog was treated with oral administration of tetracycline and niacinamide during an 8-month period. There was no indication of recurrence of the sublingual mass 2-years following treatment.

21 March 2025 in Veterinary Dermatology
Verified
Journal Article
Open access
ALA. Lange
A. Lange
UMU. Mayer
U. Mayer
EBEmmanuel Bensignor
Emmanuel Bensignor
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
DFD. Ferreira
D. Ferreira
OFO. Fantini
O. Fantini
Background: Canine interdigital furunculosis (CIF) is a complex, relapsing inflammatory condition, typically complicated by deep bacterial infections requiring prolonged systemic antibiotics.Hypothesis/Objectives: This split‐body study, where dogs acted as their own control, evaluated whether the adjunctive use of fluorescent light energy (FLE) could shorten the time to clinical resolution of CIF and minimise systemic antimicrobial use.Animals: Thirty‐five client‐owned dogs with signs of interdigital furunculosis in at least two paws.Materials and Methods: This prospective, single‐blinded, randomised, split‐body multicentre clinical trial treated dogs with systemic antibiotics based on bacterial culture and sensitivity. One paw per dog was randomly selected using a coin‐toss method for weekly FLE application, while the other paw served as a control. Dogs were scored every 2 weeks over 56 days on two parameters: a global lesion score (including haemorrhagic vesicles, fistulae with draining tracts, crusts and ulcers) and neutrophils engulfing bacteria score (NES, 0–4). Time to clinical resolution and lesion scores were assessed and compared between groups.Results: At Day (D)28 and D56, the FLE group showed significantly more healed paws (50% and 88%, p = 0.021) compared to the control (17% and 54%, p = 0.008). The median time to clinical resolution was shorter for the FLE group (35 days) compared to the control group (56 days, p = 0.017). No difference in NES score was observed between groups.Conclusions and Clinical Relevance: This blinded, randomised, split‐body clinical trial demonstrated that FLE is an effective adjunctive therapy for CIF. It reduces the time to clinical resolution and increases the resolution rate while minimising the need for antibiotics.

1 August 2017
Verified
Journal Article
Open access
PDF file
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
FLFederico Leone
Federico Leone
FAFrancesco Albanese
Francesco Albanese
MBMauro Bigliati
Mauro Bigliati
NFNatalia Fanton
Natalia Fanton
AVAntonella Vercelli
Antonella Vercelli

2 October 2025 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
Luisa CorneglianiLuisa Cornegliani
Luisa Cornegliani
AWAmelia White
Amelia White
FSFrédéric Sauvé
Frédéric Sauvé
LOLaura Ordeix
Laura Ordeix
UMUrsula Mayer
Ursula Mayer
AYAnthony Yu
Anthony Yu
Background: Fluorescent Light Energy (FLE) is a promising alternative to systemic therapies in veterinary dermatology and surgery for managing skin conditions and improving the quality of life of animals and their owners. Hypothesis/objectives: In the absence of specific recommendations for FLE use, an international DELPHI consensus research project was conducted to establish best practices. Methods: An international Steering Committee (SC) of a board-certified veterinary surgeon and veterinary dermatologists combined a literature review with clinical expertise to create recommendations. General practitioners and veterinarians of various specialties were selected to review and vote on the recommendations. Votes were collected electronically, independently, and anonymously. Results: The statements covering the following topics were analyzed in this paper: (i) Understanding photobiomodulation via FLE; (ii) Indications and Protocols for FLE; and (iii) FLE pet owner information. Consensus was reached on 33 out of 33 statements (100%) addressing the use of photobiomodulation via FLE; the practical modalities of FLE as monotherapy or adjunct therapy; healing biological benefits of photobiomodulation; reduction of antibiotic use in the management of bacterial skin infections; clinical indications where FLE can show the most favorable results along with protocols and duration of treatment; and communication with animal owners on safety measures and FLE’s benefits for their animal. Conclusions and clinical importance: This consensus provides practical guidelines on the utilization, application, and benefits of FLE when addressing veterinary dermatological conditions. It contributes to optimizing animal and owner welfare and bridges the gap between expert recommendations and the real-life experiences of general practice veterinarians.